Natural History, Prognosis, and Lipid Abnormalities of Idiopathic Ischemic Childhood Stroke
- 1 July 1996
- journal article
- research article
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 11 (4) , 276-282
- https://doi.org/10.1177/088307389601100403
Abstract
A study was performed to assess the natural history, prognostic factors, and lipid and apolipoprotein abnormalities of idiopathic ischemic childhood stroke. A case series of 42 children, retrospectively identified with idiopathic ischemic strokes, were reassessed an average of 7.4 years (range, 1 to 19 years) after presentation. Patients were interviewed and examined, and fasting serum was obtained for lipid and apolipoprotein analysis. Poor outcome was defined as moderate to severe hemiparesis, special educational needs, epilepsy, recurrent stroke, or stroke-related death. Eighteen (43%) of the patients had a poor outcome. Among them were moderate to severe hemiparesis in 14 (78%), recurrent strokes in seven (39%), and one death. Poor outcome was evident early in their clinical course. Independent of outcome, lipid abnormalities including an elevated triglyceride and low-density lipoprotein cholesterol, and a depressed high-density lipoprotein cholesterol were seen in one third of all patients. A depressed ratio of apolipoprotein A-1 to apolipoprotein B (using adult normative values) was seen in half of the entire cohort. Clinical features of children with unexplained ischemic strokes at presentation and their subsequent course are described. Significant risk factors for a poor outcome include (1) persistence of hemiparesis 1 month after the stroke, (2) cortical as opposed to subcortical location, and (3) bilateral occlusive disease with telangiectasia on cerebral angiography. Previously described risk factors for an unfavorable prognosis, including occurrence during infancy and presentation with seizures, were not substantiated. Lipid abnormalities occur at an increased frequency in children after unexplained ischemic strokes. Prospective assessment of lipoprotein profiles are needed to further assess clinical significance. Assessing apolipoproteins may provide further insight than lipid values alone. (J Child Neurol 1996;11:276-282).Keywords
This publication has 54 references indexed in Scilit:
- Lipoprotein(a) and apolipoproteins B and A-1 in children and coronary vascular events in their grandparentsThe Journal of Pediatrics, 1993
- Impact of within-person variability on identifying children with hypercholesterolemia: Framingham children's studyThe Journal of Pediatrics, 1992
- Prognosis and MRI after ischemic stroke of the basal gangliaPediatric Neurology, 1992
- Presentation, clinical course, and outcome of childhood strokePediatric Neurology, 1991
- Cholesterol screening in childhood: Sixteen-year Beaver Coynty Lipid Study experienceThe Journal of Pediatrics, 1991
- The Relation of Apolipoproteins A-I and B in Children to Parental Myocardial InfarctionNew England Journal of Medicine, 1986
- The migraine syndrome in children and adolescentsPediatric Neurology, 1986
- Cholesterol screening in childhood: Does it predict adult hypercholesterolemia? The Beaver County experienceThe Journal of Pediatrics, 1983
- Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery DiseaseNew England Journal of Medicine, 1983
- Stroke in the Young: A Four-Year Study, 1968 to 1972Stroke, 1975